University of Washington Workday #1202167

University of Washington RFI for Clinical LC-MS/MS Platform Solutions and Support

The University of Washington's Department of Laboratory Medicine and Pathology is seeking information from vendors on clinical LC-MS/MS (liquid chromatography-tandem mass spectrometry) platform solutions and related support for high-throughput clinical testing. - Government Buyer: - University of Washington, Department of Laboratory Medicine and Pathology - Products/Services Requested: - Two clinical LC-MS/MS platform solutions (triple-quadrupole tandem mass spectrometry systems) - Must support approximately 100,000 assays per year (high-throughput clinical testing) - Includes associated instrumentation, acquisition/data processing/reporting software, and integration with laboratory information systems (LIS/LIMS) - Support services including: - Service and maintenance models - Training and implementation approaches - Infrastructure requirements (gas, power, space) - Pricing models (including volume-based or phased procurement discounts) - Unique/Notable Requirements: - Vendors must provide detailed solution configurations and transparent, high-level information - Ability to support high-throughput clinical laboratory operations - Completion of confidentiality and MWBE participation forms required - Vendors may be asked to identify subject matter experts for consultation - No specific OEMs or vendors are named in the RFI; the university is gathering market information to inform future procurement.

Description

The University of Washington Department of Laboratory Medicine and Pathology is seeking Statements of Information from qualified vendors regarding clinical LC-MS/MS platform solutions and associated support. The department currently operates eight clinical triple-quadrupole tandem mass spectrometry systems and needs to acquire two additional clinical LC-MS/MS platforms. The purpose of this RFI is to gather market insights on available technologies, service models, implementation approaches, and indicative pricing to inform procurement strategy and ensure alignment with clinical, operational, and long-term planning needs. Vendors are expected to provide high-level information on instrument options, software capabilities, integration, service models, training, infrastructure requirements, and pricing.

View original listing